<VariationArchive VariationID="3062093" VariationName="NM_000834.5(GRIN2B):c.1335_1338del (p.Asp447fs)" VariationType="Deletion" Accession="VCV003062093" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-03-23" DateCreated="2024-03-23" MostRecentSubmission="2024-03-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3222321" VariationID="3062093">
      <GeneList>
        <Gene Symbol="GRIN2B" FullName="glutamate ionotropic receptor NMDA type subunit 2B" GeneID="2904" HGNC_ID="HGNC:4586" Source="calculated" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12p13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="13537337" stop="13982134" display_start="13537337" display_stop="13982134" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="13714409" stop="14133021" display_start="13714409" display_stop="14133021" Strand="-" />
          </Location>
          <OMIM>138252</OMIM>
          <Haploinsufficiency last_evaluated="2019-09-25" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GRIN2B">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2019-09-25" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GRIN2B">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000834.5(GRIN2B):c.1335_1338del (p.Asp447fs)</Name>
      <CanonicalSPDI>NC_000012.12:13615654:TGTTT:T</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>12p13.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="13615655" stop="13615658" display_start="13615655" display_stop="13615658" variantLength="4" positionVCF="13615654" referenceAlleleVCF="CTGTT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="13768589" stop="13768592" display_start="13768589" display_stop="13768592" variantLength="4" positionVCF="13768588" referenceAlleleVCF="CTGTT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>D447fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.13768590_13768593del" Assembly="GRCh37">
            <Expression>NC_000012.11:g.13768590_13768593del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.13615656_13615659del" Assembly="GRCh38">
            <Expression>NC_000012.12:g.13615656_13615659del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_031854.2" sequenceAccession="NG_031854" sequenceVersion="2" change="g.371355_371358del">
            <Expression>NG_031854.2:g.371355_371358del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000834.5" sequenceAccession="NM_000834" sequenceVersion="5" change="c.1335_1338del" MANESelect="true">
            <Expression>NM_000834.5:c.1335_1338del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000825.2" sequenceAccession="NP_000825" sequenceVersion="2" change="p.Asp447fs">
            <Expression>NP_000825.2:p.Asp447fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001413992.1" sequenceAccession="NM_001413992" sequenceVersion="1" change="c.1335_1338del">
            <Expression>NM_001413992.1:c.1335_1338del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001400921.1" sequenceAccession="NP_001400921" sequenceVersion="1" change="p.Asp447fs">
            <Expression>NP_001400921.1:p.Asp447fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000834.5(GRIN2B):c.1335_1338del (p.Asp447fs) AND Intellectual disability, autosomal dominant 6" Accession="RCV003985203" Version="1">
        <ClassifiedConditionList TraitSetID="7514">
          <ClassifiedCondition DB="MedGen" ID="C3151411">Intellectual disability, autosomal dominant 6</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-04-22" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-04-22" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-03-23" MostRecentSubmission="2024-03-23">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="7514" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16103" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES</ElementValue>
                <XRef Type="MIM" ID="613970" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Intellectual disability, autosomal dominant 6</ElementValue>
                <XRef ID="MONDO:0013509" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MRD6</ElementValue>
                <XRef Type="MIM" ID="613970" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">GRIN2B-related neurodevelopmental disorder is characterized by mild to profound developmental delayÂ / intellectual disability (DD/ID) in all affected individuals. Muscle tone abnormalities (spasticity and/or hypotonia, occasionally associated with feeding difficulties), as well as epilepsy and autism spectrum disorder (ASD) / behavioral issues, are common. Other infantile- or childhood-onset findings include microcephaly; dystonic, dyskinetic, or choreiform movement disorder; and/or cortical visual impairment. Brain MRI reveals a malformation of cortical development in a minority of affected individuals. To date, fewer than 100 individuals with GRIN2B-related neurodevelopmental disorder have been reported.</Attribute>
                <XRef ID="NBK501979" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12851" />
                <XRef ID="12851" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29851452</ID>
                <ID Source="BookShelf">NBK501979</ID>
              </Citation>
              <XRef ID="C3151411" DB="MedGen" />
              <XRef ID="MONDO:0013509" DB="MONDO" />
              <XRef Type="MIM" ID="613970" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="8977650" SubmissionDate="2024-03-19" DateLastUpdated="2024-03-23" DateCreated="2024-03-23">
        <ClinVarSubmissionID localKey=":Chr.12_13768588_13768592_CTGTT_C|OMIM:613970" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004801546" DateUpdated="2024-03-23" DateCreated="2024-03-23" Type="SCV" Version="1" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-04-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The GRIN2B c.1335_1338delAACA p(.Asp447ArgfsTer25) variant causes a shift in the protein reading frame that is predicted to result in premature termination of the protein. Loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay is expected. To our knowledge, this variant has not been reported in the peer-reviewed literature. This variant is not observed in version 2.1.1 of the Genome Aggregation Database. The variant was identified in a de novo state in the proband. Based on the available evidence, the c.1335_1338delAACA p(.Asp447ArgfsTer25 variant is classified as pathogenic for intellectual developmental disorder, autosomal dominant 6, with or without seizures.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSLVariantClassificationCriteria RUGD 01 April 2020</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/dy7elfgy/icslvariantclassificationcriteria_rugd_01_april_2020.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="12" alternateAllele="C" referenceAllele="CTGTT" start="13768588" stop="13768592" variantLength="5" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="613970" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14324016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8977650" TraitType="Disease" MappingType="XRef" MappingValue="613970" MappingRef="OMIM">
        <MedGen CUI="C3151411" Name="Intellectual disability, autosomal dominant 6" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

